The Effects of the Blood‐Based S2,3PSA% Test on Prostate Cancer Screening: A Novel Approach to Reduce the Need for MRI and Unnecessary Biopsies
S2,3PSA% screening may have potential as a tool to reduce the need for MRI, unnecessary biopsies, and medical costs.
Authors
- Hirotake Kodama (ORCID: https://orcid.org/0000-0002-5071-5149)
- Shingo Hatakeyama (ORCID: https://orcid.org/0000-0002-0026-4079)
- Shingo Kakeda (ORCID: https://orcid.org/0000-0002-0521-9728)
- Hiroyuki Sato (ORCID: https://orcid.org/0000-0003-1399-8140)
- Teppei Okamoto (ORCID: https://orcid.org/0000-0002-3750-3811)
- Naoki Fujita (ORCID: https://orcid.org/0000-0001-8284-9582)
- Kyo Togashi
- Fumiyasu Tsushima (ORCID: https://orcid.org/0000-0003-1806-8233)
- Tomoko Hamaya
- Hikari Miura
- Akio Yoneyama (ORCID: https://orcid.org/0000-0001-6925-6723)
- Chikara Οhyama (ORCID: https://orcid.org/0000-0003-1550-8379)
- Tohru Yoneyama
- Kazuyuki Mori
- Yuki Miura (ORCID: https://orcid.org/0000-0003-0963-3341)
- Tadashi Shimoyama
- Hayato Yamamoto
- Sosuke Omizo
Institutions
- Hirosaki University (JP)
Publication Details
- Journal
- The Prostate
- Published
- 2025-05-22
- DOI
- https://doi.org/10.1002/pros.24917
- Citations
- 5
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 7.59